Drug Coated PTA Balloon Catheter
OVERVIEW
Drug CoatedBalloon Catheter
ENSURE EFFECTIVE DRUG DELIVERY OF A SAFE THERAPEUTIC DOSAGE
The drug eluting balloon catheter, a versatile and effective PAD treatment option, features unique Coating Technology and is available on the 0.014”, 0.018” and 0.035” balloon catheter platforms.
Product Features
Drug Coated PTACoatingBalloon Catheter
A carrrier or an excipient is not always necessary
Coating Technology
01
The DCB drug dose of paclitaxel is 3μg/mm².
02
UltraFree™ Coating Technology effectively controls paclitaxel crystallization process, resulting in a uniform and stable microcrystal drug coating.
03
Particle size distribution test results show that 75% of the particles related are in 5-10μm range.
04
The integrated UltraFree™ coating prevents the early drug flaking during the procedure preparation and the device tracking.
05
UltraFree™ Coating quickly disintegrates into microcrystalline particles at the lesion site and allows rapid drug transfer to the arterial wall.
06
The effective drug tissue concentration at the lesion site lasts for more than 90 days.
More options with the clinically proven platforms
The DCB is based upon the PTA balloon platform and features
Low entry profile and excellent crossability
Advanced pushability
Long balloon lengths up to 220mm
ORDER INFORMATION
|
ZENFLuxion-35 |
|
|
Catheter Type |
Over-The-Wire(OTW) |
|
Guidewire |
|
|
Catheter Tip |
Flexible, short and cone-shaped |
|
Balloon Material |
Nylon |
|
Fold |
Three / six folds |
|
Coating |
Paclitaxel coating |
|
Marker |
2 |
|
Balloon Size |
Diameter:4.0~12.0mm; Length:20~220mm |
|
Shaft |
4~8F |
|
Usable Length |
110cm and 130cm |
INDICATIONS
Drug Coated PTA Balloon Catheter
The ZENFLUXION™ Drug-coated PTA Balloon Catheters are indicated for Percutaneous Transluminal Angioplasty (PTA) of stenosis or occlusion lesions in iliac, femoral or popliteal arteries.
As a fully integrated medical device company, zylox tonbridge medical technologyhasstrong R&D and manufacturing capabilities, multiple specialized technology platforms, and proven commercialization capabilities. Led by our talented management team, we strive to provide best medical services and cutting-edge technical solutions to physicians and patients in China and around the world
Send product request
Other supplier products
 |
Peripheral Vascular Treatment | Peripheral Vascular Treatment What Is Peripheral Vascular Disease? Peripheral Vascular Disease (PVD) refers to conditions that affect blood ves... |
 |
PTA Balloon Catheter | EASY ACCESS TO THE MOST CHALLENGING ANATOMIES The PTA cathetersare non-reusable semi-compliant coaxial design catheters consisting of an OTWballoo... |
 |
PTA Balloon Catheter | OVERVIEW PTA Balloon Catheter EASY ACCESS TO THE MOST CHALLENGING ANATOMIES The PTA cathetersare non-reusable semi-compliant coaxial design cath... |
 |
Company News | Zylox-Tonbridge was Added to the FTSE Global Equity Index Series Zylox Tonbridge(2190.HK, "the Company") is pleased to learn that the Company's ... |
 |
Glycine™ Microcatheter for Clot Retriever | OVERVIEW Glycine™ Microcatheter for Clot Retriever Designed to provide smooth navigation and ensure accurate deployment of devices PRODU... |
